BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 2997418)

  • 1. Mechanism of renal concentration of technetium-99m glucoheptonate.
    Lee HB; Blaufox MD
    J Nucl Med; 1985 Nov; 26(11):1308-13. PubMed ID: 2997418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tc-99m DMSA renal uptake: influence of biochemical and physiologic factors.
    Yee CA; Lee HB; Blaufox MD
    J Nucl Med; 1981 Dec; 22(12):1054-8. PubMed ID: 6273511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of cyclosporine nephrotoxicity in rats with various renal radioactive agents.
    McAfee JG; Thomas FD; Subramanian G; Roskopf M; Hellwig B
    J Nucl Med; 1988 Sep; 29(9):1577-81. PubMed ID: 2842472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal handling of technetium-99m DMSA: evidence for glomerular filtration and peritubular uptake.
    de Lange MJ; Piers DA; Kosterink JG; van Luijk WH; Meijer S; de Zeeuw D; van der Hem GK
    J Nucl Med; 1989 Jul; 30(7):1219-23. PubMed ID: 2544699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal handling of technetium-99m DMSA in rats with proximal tubular dysfunction.
    Provoost AP; Van Aken M
    J Nucl Med; 1985 Sep; 26(9):1063-7. PubMed ID: 2993552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of DMSA loading on the renal handling of technetium-99m in rats.
    Provoost AP; Van Aken M
    Uremia Invest; 1985-1986; 9(2):147-50. PubMed ID: 3020757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poor technetium-99m-DMSA renal uptake with near normal technetium-99m-DTPA uptake caused by tubulointerstitial renal disease.
    Quinn RJ; Elder GJ
    J Nucl Med; 1991 Dec; 32(12):2273-4. PubMed ID: 1660540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poor renal uptake of technetium-99m-DMSA and technetium-99m-MDP in a patient with Fanconi syndrome and near normal glomerular filtration rate.
    Kim SE; Cho JT; Lee DS; Chung JK; Kim S; Lee MC; Lee JS; Koh CS
    J Korean Med Sci; 1994 Feb; 9(1):29-34. PubMed ID: 8068216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A kinetic model for 99mTc-DMSA in the rat.
    Maneval DC; D'Argenio DZ; Wolf W
    Eur J Nucl Med; 1990; 16(1):29-34. PubMed ID: 2155115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and biological characteristics of 99mTc-diol a renal agent.
    Castanheira I; Sawas-Dimopoulou C; Paulo A; Neves M; Patricio L
    Nucl Med Biol; 1993 Apr; 20(3):279-85. PubMed ID: 8485487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the relative 99mTc-DMSA clearance a useful marker of proximal tubular dysfunction?
    van Luijk WH; Ensing GJ; Meijer S; Donker AJ; Piers DA
    Eur J Nucl Med; 1984; 9(10):439-42. PubMed ID: 6096147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of altered physiologic states on clearance and biodistribution of technetium-99m MAG3, iodine-131 OIH, and iodine-125 iothalamate.
    Taylor A; Eshima D
    J Nucl Med; 1988 May; 29(5):669-75. PubMed ID: 2967354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technetium-99m dimercaptosuccinic acid uptake in long-term catheterized kidney. Comparison with renal function.
    Higashihara E; Tokuda H; Kishi H; Niijima T; Okada Y; Nishikawa J; Iio M
    Urology; 1988 Apr; 31(4):327-31. PubMed ID: 2832996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxygen bubbling can improve the labelling of pentavalent technetium-99m dimercaptosuccinic acid.
    Kobayashi H; Suzuki KH; Sakahara H; Yao ZS; Yokoyama A; Konishi J
    Eur J Nucl Med; 1995 Jun; 22(6):559-62. PubMed ID: 7556304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal radiopharmaceuticals--an update.
    Chervu LR; Blaufox MD
    Semin Nucl Med; 1982 Jul; 12(3):224-45. PubMed ID: 6289454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Quantification of separate renal function using Tc 99m DTPA and Tc 99m DMSA. Correlations between individual isotopic data and creatinine clearance].
    Chevet D; Moisan A; Le Pogamp P; Le Cloirec J; Wehbe B; Herry JY
    Nephrologie; 1984; 5(1):21-5. PubMed ID: 6328339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical study concerning upper urinary tract obstruction. 2. Relationship between 99mTc-DMSA uptake in obstructed kidneys and their functions].
    Murayama T; Yamada T; Taguchi H; Watanabe Y; Tasei Y
    Hinyokika Kiyo; 1983 Nov; 29(11):1463-8. PubMed ID: 6328957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 99mTc-aprotinin: comparison with 99mTc-DMSA in normal and diseased kidneys.
    Aprile C; Saponaro R; Villa G; Lunghi F
    Nuklearmedizin; 1984 Feb; 23(1):22-6. PubMed ID: 6203101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tubular reabsorption of technetium-99m-DMSA.
    Müller-Suur R; Gutsche HU
    J Nucl Med; 1995 Sep; 36(9):1654-8. PubMed ID: 7658227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of vincristine on the biodistribution of technetium-99m DTPA, GHA, and DMSA in Balb/c female mice.
    Mattos DM; Gomes ML; Freitas RS; Boasquevisque EM; Cardoso VN; Paula EF; Bernardo-Filho M
    J Nucl Med Technol; 2000 Dec; 28(4):271-4. PubMed ID: 11142330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.